CONMED CORPORATION Long-Term Debt, Maturity, Remainder of Fiscal Year
CONMED CORPORATION (CNMD) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $11.25 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-07-29
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $11.25M.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $11.25M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-26 |
| 2023-06-30 | $70.00M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $70.00M 10-Q · filed 2023-04-27 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-27 |
| 2022-06-30 | $0.00 10-Q · filed 2022-07-28 |
| 2022-03-31 | $8.94M 10-Q · filed 2022-05-05 |
| 2021-09-30 | $2.98M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $9.94M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $14.91M 10-Q · filed 2021-04-29 |
| 2020-09-30 | $3.31M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $6.63M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $9.94M 10-Q · filed 2020-04-30 |
| 2019-09-30 | $3.31M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $6.63M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $10.77M 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |